Almost four months after reporting that it had secured an FDA nod for its B-Laser atherectomy system, Eximo Medical Ltd. has seen the launch and first commercial use of the device for treatment of peripheral vascular disease. "We are starting with OBL (Office Based Labs) and then expanding to hospitals," Yoel Zabar, CEO of the Israeli startup, told BioWorld MedTech when asked about rollout plans in the wake of the system's first use. Read More
